<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Brainstorm Cell Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Chaim Lebovits
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    MiMedx Group, Inc.

    MiMedx Group, Inc.

    MiMedxŽ is a biopharmaceutical company developing, manufacturing and marketing reg...

    MiMedxŽ is a biopharmaceutical company developi...

    Filing Type:    PU
    Sonoma Pharmaceuticals, Inc.

    Sonoma Pharmaceuticals, Inc.

    Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and mar...

    Sonoma Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    DBV Technologies S.A.

    DBV Technologies S.A.

    DBV Technologies is developing ViaskinÂŽ, an investigational proprietary technolog...

    DBV Technologies is developing ViaskinÂŽ, an in...

    Filing Type:    PU
    Histogenics Corporation

    Histogenics Corporation

    Histogenics historically focused on the development of restorative cell therapies,...

    Histogenics historically focused on the develop...

    Filing Type:    PU
    Amarantus Bioscience Holdings, Inc.

    Amarantus Bioscience Holdings, Inc.

    Amarantus BioSciences is a development-stage, publicly-traded biotechnology compan...

    Amarantus BioSciences is a development-stage, p...

    Amount Raised:    $4,300,000
    Fundraising Status:    VT
    Filing Type:    PR
    Celyad SA

    Celyad SA

    Celyad is a biopharmaceutical company, specialized in CAR-T cell therapy, that is ...

    Celyad is a biopharmaceutical company, speciali...

    Filing Type:    PU
    BioCardia, Inc.

    BioCardia, Inc.

    BioCardia, Inc., headquartered in San Carlos, California, is developing regenerati...

    BioCardia, Inc., headquartered in San Carlos, C...

    Filing Type:    PU
    Orgenesis Inc.

    Orgenesis Inc.

    Orgenesis is a vertically-integrated biopharmaceutical company with unique experti...

    Orgenesis is a vertically-integrated biopharmac...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    Prevail Therapeutics Inc.

    Prevail Therapeutics Inc.

    Prevail Therapeutics is applying precision medicine to the development of gene the...

    Prevail Therapeutics is applying precision medi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.